In this Q&A, Catalent Biologics experts share how scale-up, regulatory expectations, demand forecasting, and process validation all play a critical role in the success of a biologic when embarking upon the commercial manufacturing journey. https://ow.ly/Sn6R50QeCOR
Catalent Pharma Solutions’ Post
More Relevant Posts
-
Catalent will be presenting in Barcelona for #PEGS Europe Nov 5-7! Attend our poster session and talk to our Senior Director Laura Delay. Learn more about our latest updates for GPEx® Lightning cell line development technology. https://ow.ly/lNH350TNWTi
-
-
Join us for this expert speaking session at Supply Side West! Hear from Pat Vesay, Head of Marketing & Strategy, Catalent Consumer Health, and Brandon Casteel, VP of Partnerships, SPINS on key market trends and strategies to accelerate your brand’s growth. Don't miss it! https://ow.ly/5jsK50TBF0k
-
-
Recently Catalent hosted a Day of Cell Therapy Insights at our flagship European site in Gosselies, Belgium. This exclusive event brought together key stakeholders in the field for a day of discussions and exchanging ideas. It featured a thought-provoking panel on ‘Advancing Patient Access to Cell Therapies in Europe and the UK’- led by Catalent’s Delara Motlagh, joined by Rob Allen, Elisabetta Zanon, Anna van Muyden, Frédéric Druck. We were honoured to have Catalent’s Nirupama (Rupa) Pike talking about our UpTempo℠ CAR-T platform, a flexible CGMP-ready process, and special guest Stephen Ward from Cell and Gene Therapy Catapult sharing valuable lessons in manufacturing cell therapies. The day ended with a site tour and networking session. Thank you to everyone who attended! The engagement was truly inspiring! 💡 #Gosselies #CellTherapy #GeneTherapy
-
-
Complex biotherapeutics often require co-expression of multiple genes resulting in manufacturing challenges. Catalent Biologics' GPEx® Lightning system enables faster development of complex biotherapeutics by allowing precise control over gene expression, solving key manufacturing challenges. Learn more here! #Biologics #GPEX https://ow.ly/4gfp50THe7J
-
-
Join the Catalent Inhalation team in NYC for #RESCONSummit and hear Mark Ignaczak present on the latest trends in #nasal drug delivery. Be there to catch all the insights! Schedule a meeting today! https://ow.ly/VEB650TN48l
-
-
Join Catalent at #AAPS to explore phase-appropriate strategies for speeding up drug development. Discover how our developability assessment, PBPK modeling, and solutions enhance Phase 1 readiness and drive success with Lisa Caralli. https://ow.ly/QAy650TAGTU
-
-
Join this webcast and explore the flexibility and adaptability that GPEx® Lightning can offer for your next-generation biologics development needs. Discover how your team can leverage its unique advantages for commercial success. https://ow.ly/oq7X50TMGT9
-
-
Visit our Schorndorf, Germany site which offers integrated pharma product development, manufacturing and packaging, ensuring a reliable large-scale supply. Learn more: https://ow.ly/ox3P50TMc3G
-
-
Catalent’s formulation development and integrated manufacturing services can help you navigate the complexities of drug development and do it utilizing a one-roof solution. Access our case study to learn how. https://ow.ly/Ntpy50TMb0F #biologics #CDMO
-
-
Gain insight into the latest trends for oral solid dose manufacturing and how computerized modelling tools can optimize costs and improve scale-up and efficiency. Read here: https://ow.ly/eqyQ50TBiEW
-
